Browse Title Index

Issue Title
Vol 15, No 4 (2015) Characteristics of calcaneal osteomyelitis: an unusual and severe form of diabetic foot disease Abstract   HTML   PDF
Sheila M Grecian, Paul J Chadwick, Samantha J Haycocks, Paul R Chadwick, Robert J Young, Angela N Paisley
Vol 16, No 1 (2016) Childhood obesity: enough discussion, time for action Details   HTML   PDF
Colin Michie
Vol 16, No 1 (2016) Childhood obesity: enough discussion, time for action Details
Colin Michie
Vol 15, No 2 (2015) Clinical inertia in the management of type 2 diabetes mellitus: a focused literature review Abstract   HTML   PDF
Sachin Khunti, Melanie J Davies, Kamlesh Khunti
Vol 16, No 4 (2016) Clinical use of Humulin R U-500 insulin in the UK: results of the first Association of British Clinical Diabetologists’ U-500 audit Abstract   HTML   PDF
Umesh Dashora, Andrew Macklin, Bob Ryder, Erwin Castro, ABCD Nationwide U-500 Audit Contributors
Vol 17, No 4 (2017) Coenzyme Q10 supplementation for diabetes and its complications: an overview Abstract   HTML   PDF
David Mantle
Vol 16, No 3 (2016) Combining SGLT2 inhibitor and GLP-1 agonist: exaggerated weight loss in a morbidly obese patient with type 2 diabetes Details   HTML   PDF
Kg Nilwala U Jayasinghe, Veronica J Greener, Michael D Feher
Vol 14, No 3 (2014) Commissioning and the future of diabetes care Abstract   HTML   PDF
Vijay Jayagopal, Rebecca Field, Tara Kadis, Jordan Mckie, John Haigh, Andrew Bucklee, Jonathan Thow
Vol 15, No 2 (2015) Community diabetes in South London Abstract   HTML   PDF
Mark Chamley
Vol 17, No 2 (2017) Conference Abstracts from 3rd joint meeting of ABCD and the Renal Association Details   PDF
ABCD and the Renal Association
Vol 14, No 4 (2014) Consensus recommendations for the use of Ambulatory Glucose Profile in clinical practice Abstract   HTML   PDF
Stephan Matthaei, Ramiro Antuña DeAlaiz, Emanuele Bosi, Mark Evans, Nel Geelhoed-Duijvestijn, Michael Joubert
Vol 16, No 2 (2016) Coordinating care in acute diabetes foot problems: no mean feet! Abstract   HTML   PDF
Shahlaa Walsh, Roselle Herring, Helen Griffith, Julie Kohls-Gatzoulis, Sue Davidson
Vol 16 (2016): Supplement 1 Current methods of assessing blood glucose control in diabetes Abstract   HTML   PDF
Mark Evans
Vol 14, No 4 (2014) Dapagliflozin: Clinical practice compared with pre-registration trial data Abstract   HTML   PDF
Andrew P McGovern, Nina Dutta, Neil Munro, Kenneth Watters, Michael Feher
Vol 15, No 3 (2015) DAWN: Diabetes Appointments via Webcam in Newham Abstract   HTML   PDF
Shanti Vijayaraghavan, Teresa O'Shea, Desiree Campbell-Richards, Rita Sudra, Joanne Morris, Emma Byrne, Trisha Greenhalgh
Vol 14, No 2 (2014) Delivering ‘Results to Patients’ builds partnerships and facilitates diabetes care planning Abstract   HTML   PDF
Pushpa Singh, Andy Hayling, Peter H Davies
Vol 17, No 1 (2017) Desensitisation to subcutaneous insulin using CSII followed by i-Port Advance™ Details   HTML   PDF
Rob Gregory, Dawn Ackroyd, Hamidreza Mani, Alexandra Croom
Vol 15, No 1 (2015) Developing a Diabetes Smartphone App Details   HTML   PDF
Serife Mehmet
Vol 18, No 2 (2018): April / May / June 2018 Diabetes and kidney disease: insult added to injury Details   PDF   HTML
Peter Winocour
Vol 16, No 4 (2016) Diabetes and pruritus Abstract   HTML   PDF
Parastoo Babakinejad, Shernaz Walton
Vol 16, No 4 (2016) Diabetes and the NHS in England in November 2016 Details   HTML   PDF
Jonathan Valabhji
Vol 15, No 3 (2015) Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period (NG3) Abstract   HTML   PDF
Jonathan Webber, Mary Charlton, Nina Johns
Vol 15, No 4 (2015) Diabetes medications with cardiovascular protection in the wake of EMPA-REG OUTCOME: the optimal combination may be metformin, pioglitazone and empagliflozin Details   HTML   PDF
Robert EJ Ryder, Ralph A Defronzo
Vol 17, No 4 (2017) Diabetes medications with cardiovascular protection in the wake of EXSCEL: is there a class effect for long-acting GLP-1 receptor agonists? Details   HTML   PDF
Bob Ryder, Ralph A DeFronzo
Vol 16, No 3 (2016) Diabetes medications with cardiovascular protection – what now after LEADER®? Could metformin, pioglitazone, empagliflozin and liraglutide complement each other to save lives? Details   HTML   PDF
Robert EJ Ryder, Ralph A DeFronzo
76 - 100 of 254 Items << < 1 2 3 4 5 6 7 8 9 10 > >>